Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
Annual & Financial Reports
Heading &
Sub-heading can be edited through HQI
Investors
>
Annual & Financial Reports
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Annual & Financial Reports
21-Feb-2025
Appendix 4D and FY25 Half Year Financial Report
20-Sep-2024
2024 Annual Report
30-Jul-2024
Quarterly Activities Report and Appendix 4C - June 2024
30-Apr-2024
Quarterly Activities Report and Appendix 4C - March 2024
23-Feb-2024
Appendix 4D and FY24 Half Year Financial Report
27-Sep-2023
2023 Annual Report
30-Aug-2023
Appendix 4E and Preliminary Financial Report
28-Jul-2023
Appendix 4C and Quarterly Activities Report - June 2023
28-Apr-2023
Appendix 4C and Quarterly Activities Report - March 2023
24-Feb-2023
Appendix 4D and FY23 Half Year Report
31-Jan-2023
IIQ Appendix 4C and Quarterly Activities Report - December 2022
28-Sep-2022
2022 Annual Report and update on results
30-Aug-2022
Appendix 4E and Preliminary Financial Report
29-Apr-2022
IIQ Appendix 4C & Quarterly Activities Report - March 2022
25-Feb-2022
Appendix 4D and Half Year Financial Report
29-Oct-2021
Appendix 4C & Quarterly Activities Report
20-Oct-2021
Amended Remuneration Table Directors Report
29-Sep-2021
2021 Annual Report
31-Aug-2021
Appendix 4E and Preliminary Financial Report
30-Jul-2021
Appendix 4C & Quarterly Activities Report
30-Apr-2021
Appendix 4C and Quarterly Activities Report
26-Feb-2021
Appendix 4D and Half-year financial report
29-Jan-2021
Appendix 4C & Quarterly Activities Report
30-Oct-2020
Appendix 4C and Quarterly Activities Report
25-Aug-2020
Appendix 4E and Annual Report to Shareholders
29-Apr-2020
Quarterly Activities Report & Appendix 4C
25-Feb-2020
Half Yearly Report and Accounts
30-Jan-2020
Appendix 4C Quarterly Cashflow Report
19-Dec-2019
Appendix 4E and Annual Report to Shareholders
28-Feb-2019
Half Yearly Report and Accounts
25-Jan-2019
Quarterly Business Update and Appendix 4C
31-Oct-2018
Quarterly Activities Report and Cashflow
1-Oct-2018
Annual Report to Shareholders
1-Aug-2018
Quarterly Activities Report and Appendix 4C
28-Feb-2018
Half Yearly Report and Accounts
29-Sep-2017
Annual Report to Shareholders
27-Jul-2017
Quarterly Activities Report & Appendix 4C
28-Apr-2017
Quarterly Activities Report and Appendix 4C
28-Feb-2017
Appendix 4D and Half Yearly Reports and Accounts
31-Oct-2016
Quarterly Activities Report and Appendix 4C
19-Oct-2016
Annual Report to Shareholders
30-Sep-2016
Statutory Audited Financial Statements
31-Aug-2016
Preliminary Final Report - Appendix 4E
28-Jul-2016
Quarterly Activities Report and Appendix 4C
